AstraZeneca Pharma India Limited announced unaudited earnings results for the first quarter ended June 30, 2017. For the quarter, the company’s revenue from operations was INR 1,284.658 million against INR 1,408.651 million a year ago. Total revenue was INR 1,331.199 million against INR 1,424.834 million a year ago. Profit before exceptional and extraordinary items and tax was INR 71.630 million against INR 154.977 million a year ago. Profit before tax was INR 71.630 million against INR 154.977 million a year ago. Profit for the period was INR 57.973 million against INR 126.014 million a year ago. Earnings per share-basic and diluted were INR 2.32 against INR 5.04 a year ago.